Each year, we take a wide view of the rare disease landscape to look at how technology is improving the ability to understand, diagnose, develop treatments and deliver care to patients. Using a wide range of data over the course of each year, we'll discuss advancements in rare disease, and what comes next in drug development, technology, and financial impact.